B · Normal
[The concepts of innovative drugs and CRO continue to fall, and Asymchem is approaching the limit] On October 22, the concept of innovative drugs and CRO continued to fall, with Asymchem approaching the limit, nearshore protein fell by more than 16%, and Baihua Pharmaceutical, Wanbang Pharmaceutical, Jinshi Yaoyao, Zhaoyan New Drug, CanSino, WuXi AppTec and other stocks fell by more than 5%.
Live broadcast 🕐 2026-10-22 13:25
#Live broadcast #CRO
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Analysis of daily limit on October 22] On October 22, a total of 33 stocks in t 10-22 15:13 [Review: The GEM index opened lower and fell more than 4%, with nearly 5,000 sto 10-22 15:01 [Many broad-based ETFs increased their volume again in late trading CSI 300 ETF 10-22 14:56 [Main Fund Monitoring: Huatian Technology’s Net Buying Exceeded 600 Million] On 10-22 14:56 [Memory chip concept picked up in the afternoon, Yunhan Chip City, Huatian Techn 10-22 13:59 [The banking sector partially recovered, with Industrial and Commercial Bank of 10-22 13:53

Comments

0/500
Captcha (click to refresh)
No comments yet